Talecris Biotherapeutics Inc is categorized under Biotherapeutics in Raleigh, NC and active since 2007.
Talecris Biotherapeutics Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biotherapeutics business, which does work in the BOTH market, and is classified as a Biotherapeutics, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Gisela Fleming at the company’s single location by writing to 1017 Main Campus Drive # 1200, Raleigh, North Carolina NC 27606 or by phoning (919) 508-8728. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Talecris Biotherapeutics Inc |
| Contact Person: | Gisela Fleming |
| Address: | 1017 Main Campus Drive # 1200, Raleigh, North Carolina 27606 |
| Phone Number: | (919) 508-8728 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Biotherapeutics |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Talecris Biotherapeutics Inc was started in 2007 to provide professional Biotherapeutics under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gisela Fleming for inquiries that concern Talecris Biotherapeutics Inc by calling the company number (919) 508-8728, as your correspondence is most welcome. Additionally, the physical location of the single location of Talecris Biotherapeutics Inc can be found at the coordinates 35.769985,-78.677697 as well as the street address 1017 Main Campus Drive # 1200 in Raleigh, North Carolina 27606.
For its online presence, you may visit Talecris Biotherapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.